You just clicked a link to go to another website. If you continue, you will leave this site and go to a site run by someone else.
Medtronic does not review or control the content on the other website, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in the Indian Subcontinent.
Any and all information provided is intended for general overview. Viewers taking any decision based on the information provided herein are requested to seek professional advice.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations.
Click “OK” to confirm you are a Healthcare Professional.
The Micra™ AV and Micra™ VR leadless pacemakers are implantable, programmable cardiac devices used to monitor and regulate a patient’s heart rate.
Download brochureThe miniaturized Micra™ AV and Micra™ VR* leadless pacemakers are the world's smallest pacemakers1 for bradyarrhythmia management, delivered percutaneously via a minimally invasive approach and do not require the use of leads.
Parameter |
Micra AV2 |
Micra VR3 |
---|---|---|
Pacing mode |
VVI, VVIR, VOO, OVO, VDD, VDI, ODO, OFF |
VVI, VVIR, VOO, OVO, OFF |
Mass |
1.75 g |
1.75 g |
Volume |
0.8 cc |
0.8 cc |
Electrode spacing |
18 mm |
18 mm |
Battery longevity |
8–13 years†2,4 |
12 years‡5 |
Accelerometer-based mechanical atrial sensing |
Yes |
N/A |
Accelerometer-based rate response |
Yes |
Yes |
MRI SureScan™ |
1.5T and 3T |
1.5T and 3T |
CareLink™ remote monitoring |
Yes |
Yes |
Access interactive courses, videos, and educational resources to extend your learning on Micra.
* The single chamber Micra™ transcatheter pacing system is being described herein as Micra™ VR in order to distinguish it from the (VDD) Micra™ AV product. When information in this document relates to both Micra™ AV and VR, “Micra™ transcatheter pacing systems” is used to represent the portfolio of devices.
† Use conditions include:
8 years = 100% VDD pacing, 60 bpm, pacing threshold 1.5 V, impedance 500 Ω, pulse width 0.24 ms.
13 years = 15% VDD pacing, 70 bpm, pacing threshold 1.5 V, impedance 600 Ω, pulse width 0.24 ms.
‡ Use conditions included: median pacing 53.5%, median pacing threshold 0.50 V, median impedance 543 Ω; 89% of patients with > 10-year projected longevity; 99% of patients with > 5-year longevity.5
1. Nippoldt D, Whiting J. Micra™ transcatheter pacing system device volume characterization comparison. November 2014. Medtronic data on file.
2. Medtronic Micra™ AV MC1AVR1 Device Manual. January 2020.
3. Medtronic Micra™ MC1VR01 Clinician Manual. October 2016.
4. Pender J, Whiting J. Micra™ AV Battery Longevity. January 2020. Medtronic data on file.
5. Duray GZ, Ritter P, El-Chami M, et al. Long-term performance of a transcatheter pacing system: 12-month results from the Micra transcatheter pacing study. Heart Rhythm. May 2017;14(5):702–709. doi: 10.1016/j.hrthm.2017.01.035.